The life science research industry is a high-stakes field where growth and friction coexist. The global CRO market is projected to reach $281.1 billion by 2032, yet only 14.6% of new drugs entering clinical trials ultimately gain FDA approval. This data illustrates the scale of investment and the persistent challenge of clinical validation.
Key Takeaways
- 10.8% CAGR projected for the global contract research organization (CRO) market from 2024 to 2032, reaching US$281.1 billion by 2032
- 3.6% projected CAGR for the global laboratory services market from 2024 to 2032
- US$333.8 billion value for the global in vitro diagnostics (IVD) market in 2023
- US$3.4 billion global market for lab automation in 2024 (forecast value reported in 2024 industry report)
- 70% of labs reported productivity improvements from adopting LIMS (surveyed result in a 2022 industry benchmarking report)
- 38% reduction in transcription errors with automated ELN workflows vs manual entry reported in a 2021 validation study
- 43% of clinical trials in 2022 used electronic data capture (EDC), a rise from prior years reported by industry analytics
- 72% of life science IT decision-makers plan to deploy cloud data platforms in 2024
- US$15.3 billion value for the global digital pathology market in 2023
- 14.6% of investigational new drugs entered phase 1 and ultimately received FDA approval (median success rate across studies summarized in a 2022 peer-reviewed analysis)
- The average cost to develop and obtain FDA approval for a new drug is about US$2.6 billion (including capitalized R&D costs), per a 2023 updated estimate in a peer-reviewed paper
- Median time from IND submission to NDA approval was 8.8 years in an FDA analysis covering 2006–2015 (median across programs)
- US$1.3 billion global market for clinical trial imaging services in 2023
- US$8.2 billion global market for clinical trial supply services in 2023
- US$4.6 billion global market for biobanking services in 2023
CRO growth is accelerating with digital and automated lab systems, supported by rising IT investment and services markets.
Related reading
01 · Category
Market Size5 stats
01
10.8% CAGR projected for the global contract research organization (CRO) market from 2024 to 2032, reaching US$281.1 billion by 2032
02
3.6% projected CAGR for the global laboratory services market from 2024 to 2032
03
US$333.8 billion value for the global in vitro diagnostics (IVD) market in 2023
04
US$1.7 trillion global government R&D budget in 2022 across OECD countries (latest OECD dataset year referenced in the publication)
05
US$8.0 billion market for preclinical CRO services in 2022
Interpretation
Market Size Interpretation
Market size signals strong, sustained growth across life science research services, with the global CRO market projected to rise at a 10.8% CAGR from 2024 to 2032 and reach US$281.1 billion by 2032.
02 · Category
Productivity & Automation8 stats
01
US$3.4 billion global market for lab automation in 2024 (forecast value reported in 2024 industry report)
02
70% of labs reported productivity improvements from adopting LIMS (surveyed result in a 2022 industry benchmarking report)
03
38% reduction in transcription errors with automated ELN workflows vs manual entry reported in a 2021 validation study
04
Up to 60% faster sample preparation reported for robotic extraction workflows in a peer-reviewed paper benchmarking automated vs manual
05
30% reduction in cycle time for routine ELISA workflows after automation with plate handling robotics in a 2019 implementation study
06
US$1.9 billion global market for laboratory information management systems (LIMS) in 2022
07
FDA-regulated facilities using electronic systems have observed 26% fewer deviations after implementing automated deviation and CAPA workflows (industry evaluation study)
08
Automation can reduce reagent waste by 20%–40% in workflow optimization studies of lab automation (2018–2022 industry synthesis)
Interpretation
Productivity & Automation Interpretation
For the Productivity & Automation category, labs are seeing clear measurable gains as automation and informatics scale with a 70% LIMS adoption success rate and outcomes like 38% fewer transcription errors, up to 60% faster sample prep, and a 30% ELISA cycle time reduction, supported by large market momentum such as a US$3.4 billion lab automation forecast for 2024 and a US$1.9 billion LIMS market in 2022.
03 · Category
Industry Trends5 stats
01
43% of clinical trials in 2022 used electronic data capture (EDC), a rise from prior years reported by industry analytics
02
72% of life science IT decision-makers plan to deploy cloud data platforms in 2024
03
US$15.3 billion value for the global digital pathology market in 2023
04
US$3.9 billion global market for lab information management systems (LIMS) in 2023
05
US$2.7 billion global market for single-cell sequencing technologies in 2023
Interpretation
Industry Trends Interpretation
Industry trends in life science research point to accelerating digital transformation, with 72% of IT decision makers planning cloud data platforms in 2024 and major growth in supporting technologies as seen in the US$3.9 billion LIMS market and US$15.3 billion digital pathology market in 2023.
More related reading
04 · Category
Clinical & Validation7 stats
01
14.6% of investigational new drugs entered phase 1 and ultimately received FDA approval (median success rate across studies summarized in a 2022 peer-reviewed analysis)
02
The average cost to develop and obtain FDA approval for a new drug is about US$2.6 billion (including capitalized R&D costs), per a 2023 updated estimate in a peer-reviewed paper
03
Median time from IND submission to NDA approval was 8.8 years in an FDA analysis covering 2006–2015 (median across programs)
04
EMA received 108 applications for centralized marketing authorizations for gene therapy between 2018 and 2023 in the EMA product stats
05
Median duration from first patient in to database lock was 14 months for phase 3 trials in a 2021 peer-reviewed study
06
Randomized controlled trials remain the dominant trial design, representing 63% of clinical trials indexed in ClinicalTrials.gov sampled in a 2022 review
07
Across multiple studies, 50% of published biomedical research findings are estimated to be not reproducible (2016 peer-reviewed review estimate)
Interpretation
Clinical & Validation Interpretation
For the Clinical and Validation category, the odds and timelines remain steep as only 14.6% of investigational new drugs that enter phase 1 ultimately reach FDA approval and the median IND to NDA path takes 8.8 years, underscoring just how high the bar is for clinical evidence that can validate a new treatment.
05 · Category
Cost Analysis8 stats
01
US$1.3 billion global market for clinical trial imaging services in 2023
02
US$8.2 billion global market for clinical trial supply services in 2023
03
US$4.6 billion global market for biobanking services in 2023
04
US$5.1 billion global market for laboratory testing services in 2022
05
FDA’s PDUFA user fee amounts increased to US$3,258,978for a premarket application (type B) for fiscal year 2024 (fee schedule)
06
US$14.1 billion estimated global market for pharmacovigilance services in 2023
07
US$7.8 billion global market for regulatory affairs outsourcing services in 2023
08
US$3.1 billion global market for GMP consulting services in 2023
Interpretation
Cost Analysis Interpretation
The cost landscape for Life Science Research is expanding quickly, with 2023 global markets reaching US$14.1 billion for pharmacovigilance services and US$8.2 billion for clinical trial supply services, alongside major fee pressure such as the FDA’s FY2024 PDUFA level of US$3,258,978 for a premarket application type B.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Kowalski. (2026, February 13). Life Science Research Industry Statistics. Gitnux. https://gitnux.org/life-science-research-industry-statistics
MLA
David Kowalski. "Life Science Research Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/life-science-research-industry-statistics.
Chicago
David Kowalski. 2026. "Life Science Research Industry Statistics." Gitnux. https://gitnux.org/life-science-research-industry-statistics.
Sources & references
33 datasets cited across this report · attribution is report-level
+15 additional datasets cited (not shown individually)